Lilly (LLY.N) on Saturday presented Phase III results showin
文 / 小金
2026-06-07 12:00:39
来源:亚金网
Lilly (LLY.N) on Saturday presented Phase III results showing once-weekly Retatrutide promoted weight loss and reduced severity of moderate-to-severe obstructive sleep apnea by 60.6% and knee osteoarthritis pain by up to 73.1% in obese adults.
